It has been shown that sirtinol can chelate iron in NSCLC cells leading to a decrease in labile iron acutely and a cell line–specific adaptive response characterized by a decrease in aconitase activity leading to a shift toward IRP1 activation, enhanced TfR stability, and repressed FtH translation. The gene discussed is TFRC; the disease is non-small cell lung carcinoma.